IL4R and allergic disease: By reducing IL-4Rα protein expression in various lung cells, including eosinophils, dendritic cells, macrophages, and airway epithelium, the modified IL-4Rα showed promise in mitigating allergic lung inflammation and airway hyperreactivity associated with asthma/allergy [64].